Review article · 2024 · Open access

KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD

Sankar Dass Navaneethan, Nisha Bansal, Kerri L. Cavanaugh, Alex R. Chang, Susan T. Crowley, Cynthia Delgado, Michelle M. Estrella, Cybele Ghossein, Talat Alp Ikizler, Holly M. Koncicki, Wendy L. St. Peter, Katherine R. Tuttle and 1 more

American Journal of Kidney Diseases, 85(2), 135–176 · Published 18 November 2024 · DOI 10.1053/j.ajkd.2024.08.003

Free PDFView at the publisherCite this paper

In brief

“KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD” is a 2024 review article by Sankar Dass Navaneethan and 12 co-authors, published in American Journal of Kidney Diseases. OpenAlex counts 121 citations as of 15 November 2026. It is open access: the full text is free to read at American Journal of Kidney Diseases.

Citations
121
Most cited in
2026 (71)
Field-weighted impact
5.45
References
221
Authors
13

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Navaneethan, S. D., Bansal, N., Cavanaugh, K. L., Chang, A. R., Crowley, S. T., Delgado, C., Estrella, M. M., Ghossein, C., Ikizler, T. A., Koncicki, H. M., Peter, W. L. S., Tuttle, K. R., & William, J. H. (2024). KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD. American Journal of Kidney Diseases, 85(2), 135–176. https://doi.org/10.1053/j.ajkd.2024.08.003

MLA 9

Navaneethan, Sankar Dass, et al. “KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD.” American Journal of Kidney Diseases, vol. 85, no. 2, 2024, pp. 135–176. https://doi.org/10.1053/j.ajkd.2024.08.003.

Chicago

Navaneethan, Sankar Dass, Nisha Bansal, Kerri L. Cavanaugh, Alex R. Chang, Susan T. Crowley, Cynthia Delgado, Michelle M. Estrella, et al. 2024. “KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD.” American Journal of Kidney Diseases 85 (2): 135–176. https://doi.org/10.1053/j.ajkd.2024.08.003.

Harvard

Navaneethan, S. D. et al. (2024) ‘KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD’, American Journal of Kidney Diseases, 85(2), pp. 135–176. doi:10.1053/j.ajkd.2024.08.003.

IEEE

S. D. Navaneethan et al., “KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD,” American Journal of Kidney Diseases, vol. 85, no. 2, pp. 135–176, 2024, doi: 10.1053/j.ajkd.2024.08.003.

BibTeX

@article{navaneethan2024kdoqi,
  title     = {{KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD}},
  author    = {Navaneethan, Sankar Dass and Bansal, Nisha and Cavanaugh, Kerri L. and Chang, Alex R. and Crowley, Susan T. and Delgado, Cynthia and Estrella, Michelle M. and Ghossein, Cybele and Ikizler, Talat Alp and Koncicki, Holly M. and Peter, Wendy L. St. and Tuttle, Katherine R. and William, Jeffrey H.},
  journal   = {American Journal of Kidney Diseases},
  year      = {2024},
  volume    = {85},
  number    = {2},
  pages     = {135--176},
  doi       = {10.1053/j.ajkd.2024.08.003},
  url       = {https://doi.org/10.1053/j.ajkd.2024.08.003}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201711
201911
202033
202122
202233
202344
20253636
20267171

Its field-weighted citation impact is 5.45: it has been cited 5.45 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes

  • chronic kidney disease
  • chronic kidney disease progression
  • cardiovascular outcomes
  • SGLT2 inhibitors
  • GLP-1 receptor agonists
  • non-steroidal mineralocorticoid receptor antagonists
  • type 2 diabetes
  • team-based care

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Navaneethan, S. D., Bansal, N., Cavanaugh, K. L., Chang, A. R., Crowley, S. T., Delgado, C., Estrella, M. M., Ghossein, C., Ikizler, T. A., Koncicki, H. M., Peter, W. L. S., Tuttle, K. R., & William, J. H. (2024). KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD. American Journal of Kidney Diseases, 85(2), 135–176. https://doi.org/10.1053/j.ajkd.2024.08.003

How many times has this paper been cited?

121 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at American Journal of Kidney Diseases.

Who wrote this paper?

Sankar Dass Navaneethan, Nisha Bansal, Kerri L. Cavanaugh, Alex R. Chang, Susan T. Crowley, Cynthia Delgado, Michelle M. Estrella, Cybele Ghossein, Talat Alp Ikizler, Holly M. Koncicki, Wendy L. St. Peter, Katherine R. Tuttle and 1 more.

What is the DOI of this paper?

10.1053/j.ajkd.2024.08.003. The permanent link is https://doi.org/10.1053/j.ajkd.2024.08.003.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.